Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Raisman

Showing results (51-60 of 105) with videos related to

Pageof 11
Sort By:
Journal of Neurochemistry|August 1, 1981
Distribution of specific high-affinity binding sites for [3H]imipramine in human brainS Z Langer, F Javoy-Agid, R Raisman, et al.
Advances in Biochemical Psychopharmacology|January 1, 1984
3H-imipramine and 3H-desipramine binding sites in depressionS Z Langer, R Raisman, D Sechter, et al.
Brain Research|February 19, 1996
Dopaminergic sprouting in the rat striatum after partial lesion of the substantia nigraV Blanchard, P Anglade, G Dziewczapolski, et al.
Psychopharmacology|January 1, 1982
3H-imipramine binding and serotonin uptake in platelets from untreated depressed patients and control volunteersR Raisman, M S Briley, F Bouchami, et al.
Experimental Neurology|December 31, 2003
Protective effect of the alpha2-adrenoceptor antagonist, dexefaroxan, against spatial memory deficit induced by cortical devascularization in the adult ratP Chopin, T Debeir, R Raisman-Vozari, et al.
Journal of Neurochemistry|July 4, 2001
Survival promotion of mesencephalic dopaminergic neurons by depolarizing concentrations of K+ requires concurrent inactivation of NMDA or AMPA/kainate receptorsA Douhou, J D Troadec, M Ruberg, et al.
Neurology|January 1, 1987
Parkinson's disease and dementia: norepinephrine and dopamine in locus ceruleusR Cash, T Dennis, R L'Heureux, et al.
Neuroscience|October 29, 2002
Protective effects of the alpha 2-adrenoceptor antagonist, dexefaroxan, against degeneration of the basalocortical cholinergic system induced by cortical devascularization in the adult ratT Debeir, M Marien, P Chopin, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|September 1, 1980
Specific 3H-imipramine binding in human platelets. Influence of age and sexS Z Langer, M S Briley, R Raisman, et al.
Experimental Neurology|November 9, 2004
In vivo upregulation of endogenous NGF in the rat brain by the alpha2-adrenoreceptor antagonist dexefaroxan: potential role in the protection of the basalocortical cholinergic system during neurodegenerationThomas Debeir, M Marien, J Ferrario, et al.
Pageof 11

Showing results (51-60 of 105) with videos related to

Sort By:
Pageof 11
Journal of Neurochemistry|August 1, 1981
Distribution of specific high-affinity binding sites for [3H]imipramine in human brainS Z Langer, F Javoy-Agid, R Raisman, et al.
Advances in Biochemical Psychopharmacology|January 1, 1984
3H-imipramine and 3H-desipramine binding sites in depressionS Z Langer, R Raisman, D Sechter, et al.
Brain Research|February 19, 1996
Dopaminergic sprouting in the rat striatum after partial lesion of the substantia nigraV Blanchard, P Anglade, G Dziewczapolski, et al.
Psychopharmacology|January 1, 1982
3H-imipramine binding and serotonin uptake in platelets from untreated depressed patients and control volunteersR Raisman, M S Briley, F Bouchami, et al.
Experimental Neurology|December 31, 2003
Protective effect of the alpha2-adrenoceptor antagonist, dexefaroxan, against spatial memory deficit induced by cortical devascularization in the adult ratP Chopin, T Debeir, R Raisman-Vozari, et al.
Journal of Neurochemistry|July 4, 2001
Survival promotion of mesencephalic dopaminergic neurons by depolarizing concentrations of K+ requires concurrent inactivation of NMDA or AMPA/kainate receptorsA Douhou, J D Troadec, M Ruberg, et al.
Neurology|January 1, 1987
Parkinson's disease and dementia: norepinephrine and dopamine in locus ceruleusR Cash, T Dennis, R L'Heureux, et al.
Neuroscience|October 29, 2002
Protective effects of the alpha 2-adrenoceptor antagonist, dexefaroxan, against degeneration of the basalocortical cholinergic system induced by cortical devascularization in the adult ratT Debeir, M Marien, P Chopin, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|September 1, 1980
Specific 3H-imipramine binding in human platelets. Influence of age and sexS Z Langer, M S Briley, R Raisman, et al.
Experimental Neurology|November 9, 2004
In vivo upregulation of endogenous NGF in the rat brain by the alpha2-adrenoreceptor antagonist dexefaroxan: potential role in the protection of the basalocortical cholinergic system during neurodegenerationThomas Debeir, M Marien, J Ferrario, et al.
Pageof 11